Physician profile
David P Minges
NPI 1720216674
$94,691.32
in general payments reported to CMS, 2019-2025
13 companies · $37K in 2025
The $37K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2021: $2,266 · 2022: $1,715 · 2023: $49K · 2024: $4,056 · 2025: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $54K · Consulting Fee: $30K · Travel and Lodging: $4,469 · Food and Beverage: $2,487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $53,804.99 |
| Consulting Fee | $29,750.00 |
| Travel and Lodging | $4,469.44 |
| Food and Beverage | $2,486.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acuity Surgical Devices, LLC | $89,415.15 | 2021-2025 | |
| Globus Medical, INC. | $4,414.92 | 2023-2025 | Excelsius Gps, Instruments, Canopy |
| Centinel Spine, LLC | $221.06 | 2021 | |
| Depuy Synthes Sales INC. | $207.23 | 2022-2025 | |
| Spineology INC. | $198.27 | 2019 | |
| Baxter Healthcare | $66.20 | 2024-2025 | Floseal |
| Ethicon US, LLC | $43.28 | 2021-2022 | |
| Fidia Pharma USA INC. | $25.14 | 2024 | Hyalgan, Triluron, Hymovis |
| Si-Bone, INC. | $22.27 | 2021 | |
| Augmedics INC. | $21.25 | 2023 | Xvision |
| Orthofix Medical, INC. | $19.47 | 2023 | Spinal-Stim, Spinal-Stim |
| Abbott Laboratories | $19.28 | 2024 | Proclaim |
| Smith+Nephew, INC. | $17.80 | 2025 | Pico |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Minges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.